Instituto de Evaluación Tecnológica en Salud

What Instituto de Evaluación Tecnológica en Salud does

Instituto de Evaluación Tecnológica en Salud (IETS) is Colombia's official health technology assessment (HTA) institute, founded in November 2012 under the authorization of Law 1438 of 2011 and headquartered in Bogotá. Operating as a non-profit corporation of mixed participation (corporación sin ánimo de lucro y de participación mixta), it was formally attached (adscrita) to the Ministry of Health and Social Protection in 2023 under Article 160 of Law 2294, positioning it as the government's central technical body for generating independent scientific evidence on medications, medical devices, procedures, and public health programs. Its primary institutional customer is the Colombian General Social Security Health System (SGSSS), with the Ministry of Health as the principal commissioning stakeholder.

IETS's core technology consists of HTA methodologies — clinical effectiveness and safety evaluations, cost-effectiveness and cost-utility analyses, budget impact analyses, systematic reviews, clinical practice guidelines, therapeutic positioning reports, and epidemiological studies. Its product portfolio spans seventeen documented offerings organized around three pillars: assessments (effectiveness/safety, economic, budget impact), clinical standardization (GPCs, protocols, technical guidelines, clinical pathways), and policy-oriented products (policy briefs, therapeutic positioning, PBS updates). Outputs are delivered through digital platforms including the Ventanilla Virtual for clinical guidelines, Campus IETS for virtual training, a searchable technical document repository, and the dedicated COVID-19 vaccine adverse event evaluation microsite. Two AI-adjacent tools have been developed: the Geovisor de Vulnerabilidad (geospatial risk mapping) and an NLP/deep-learning recommender system for occupational hygiene.

The business model is government-funded and mandate-driven rather than commercial. Revenue derives from government transfers associated with its Ministry of Health affiliation and from project-based contracts with government entities, international organizations, and academic partners. Services are provided free of charge to public entities as part of IETS's public mission. Distribution is institutional — direct delivery to the Ministry of Health, healthcare institutions, professionals, patient organizations, and the public through official channels, supplemented by an annual international symposium and a citizen-facing communications program (La Ruta de la Evidencia). Recent momentum includes Minciencias Centro de Investigación recognition in April 2024 and structured patient-organization collaborations, offset by 2025 financial difficulties caused by delayed government disbursements.

Name

Instituto de Evaluación Tecnológica en Salud

Legal name

Instituto de Evaluación Tecnológica en Salud

Website

https://iets.org.co

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Instituto de Evaluación Tecnológica en Salud (IETS) is Colombia's official health technology assessment institute, generating independent scientific evidence — clinical, economic, and budget impact analyses plus clinical practice guidelines — to support coverage and policy decisions by the Ministry of Health and the SGSSS.

Ownership category

akta.pro rank

Product category

Health Technology Assessment Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAJACAF

Health Technology Assessment (HTA) & Reimbursement Policy Bodies

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities

SECONDARYHLAJANAL

Economic Evaluation & Health Technology Assessment (Public Programs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Program Evaluation & Surveillance

Keywords

• Health technology assessment
• Clinical practice guidelines
• Economic evaluations
• Budget impact analysis
• Health policy evidence

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Government Funding: As an entity affiliated to the Ministry of Health and Social Protection since 2023, IETS receives government funding to support its operations and mandate to generate evidence for the Colombian health system.
2. Research Projects and Contracts: The institute develops research projects funded through agreements with government entities, international organizations, and academic institutions.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Instituto de Evaluación Tecnológica en Salud (IETS) is Colombia's official health technology assessment (HTA) institute that produces independent scientific evidence on the safety, efficacy, clinical effectiveness, and cost-effectiveness of medications, medical devices, procedures, and public health programs. It develops evidence-based clinical practice guidelines, economic evaluations, budget impact analyses, clinical protocols, therapeutic positioning reports, and policy briefs to support decision-making in Colombia's General Social Security Health System (SGSSS).

Product overview

The Instituto de Evaluación Tecnológica en Salud (IETS) is Colombia's governmental health technology assessment (HTA) institute, operating as a non-profit corporation under the Ministry of Health. It functions as a unified institutional platform producing evidence-based intelligence across the health technology lifecycle. The portfolio consists of a core set of assessment services — health technology evaluations (evaluaciones de efectividad, seguridad, y validez diagnóstica), economic evaluations, and budget impact analyses — supported by standardization outputs (clinical practice guidelines, clinical protocols, technical guidelines, and clinical pathways), and policy-oriented products (policy briefs and therapeutic positioning reports). These deliverables are disseminated through digital platforms including the Ventanilla Virtual for clinical guidelines, the Campus IETS for virtual training, and a technical document repository. Complementary offerings include horizon scanning, a COVID-19 vaccine adverse event evaluation council, and an international symposium series.

Differentiator

Problem solved

Functional benefit

Products and services

• Evaluación de Tecnologías Sanitarias (Health Technology Evaluation) Production of independent scientific evidence on the safety, efficacy, clinical effectiveness, and diagnostic validity of medications, medical devices, procedures, and public health programs for the Colombian health system.
• Guías de Práctica Clínica (Clinical Practice Guidelines) Evidence-based clinical practice guidelines developed to standardize clinical care and rational use of health technologies in the Colombian health system.
• Evaluaciones Económicas (Economic Evaluations) Cost-effectiveness, cost-utility, and cost-benefit analyses supporting resource allocation decisions in the Colombian health system.
• Análisis de Impacto Presupuestal (Budget Impact Analysis) Quantification of the financial implications of adopting new health technologies for the health system budget.
• Protocolos Clínicos (Clinical Protocols) Clinical protocols guiding diagnosis, treatment, and care pathways for specific conditions including autism spectrum disorders, infertility, glioblastoma, and spinal muscular atrophy.
• Lineamientos Técnicos (Technical Guidelines) Technical guidelines based on evidence to standardize clinical practice and the use of health technologies in Colombia.
• Vías Clínicas (Clinical Pathways) Clinical pathways structuring step-by-step patient care processes for specific health conditions.
• Política Pública en Salud / Policy Briefs Policy briefs and technical documents supporting public health policy decisions, including updates to the Plan de Beneficios de Salud (PBS) and exclusion lists.
• Posicionamientos Terapéuticos (Therapeutic Positioning) Therapeutic positioning reports classifying health technologies for high-cost conditions including allergic rhinitis, rheumatoid arthritis, multiple myeloma, chronic pain, and organ transplants, to optimize medication prescribing.
• Centro de Investigación IETS

Quantifiable outcome

• Developed 21 therapeutic positioning documents for high-cost conditions including allergic rhinitis, rheumatoid arthritis, multiple myeloma, chronic pain, and organ transplants
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Twelve partnerships are on record, tiered core, flagship and minor.

• Patient Organizations (FAMECOLOMBIA, ACOPEL, INSPIRAT, FAHES, FUNCOLEHF, FELEHANSEN)coreStrategic or Co-development Partner · 29 August 2025IETS collaborates with multiple patient organizations to co-create tools, design training courses, and develop patient data standards for policy recommendations. The collaboration aims to integrate patient experiences and voices into health technology assessment processes, ensuring equitable decisions grounded in both scientific evidence and patient needs.
• Pontificia Universidad JaverianaflagshipStrategic or Co-development Partner · 1 January 2024Lead institution in the ÁGORA project (Alianza para la Generación de Evidencia sobre COVID-19, su Respuesta y Lecciones Aprendidas para la Postpandemia y Futuras Epidemias), generating evidence on pandemic response and health system resilience.
• Universidad de los AndescoreStrategic or Co-development PartnerPartner in the ÁGORA project contributing to evidence generation on COVID-19 response and lessons for future epidemics.
• Universidad del RosariocoreStrategic or Co-development PartnerPartner in the ÁGORA project contributing multidisciplinary research to pandemic response studies.
• Universidad Industrial de SantandercoreStrategic or Co-development PartnerPartner in the ÁGORA project contributing regional perspective to pandemic response research.
• Cuenta de Alto CostocoreStrategic or Co-development PartnerPartner providing high-cost disease registry data for cancer care analysis and evaluation studies.
• Ministerio de Ciencia, Tecnología e InnovacióncoreStrategic or Co-development PartnerGovernment ministry supporting the ÁGORA project and recognizing IETS as a Centro de Investigación.
• Universidad Santo TomáscoreStrategic or Co-development PartnerHost institution for the III Simposio Internacional de Evaluación de Tecnologías en Salud, providing venue and academic support for the 2025 symposium on sustainable and equitable health systems.
• Universidad de AntioquiacoreStrategic or Co-development PartnerAcademic partner supporting the II Simposio Internacional with venue and organizational resources through the Investigation University headquarters (SIU).
• International HTA Experts and OrganizationscoreStrategic or Co-development PartnerInternational experts including Mtr. Dra. Natalia Messina (CETSAI-ISALUD Argentina), MSc. PhD. Dr. Iñaki Gutiérrez (Gobierno Vasco, EuroScan/i-HTS), and Farm. MSc. Dr(c). Manuel Donato (CETSAI-ISALUD Argentina) participate in IETS symposiums and knowledge exchange.
• Dr. Héctor Castro (Ex-Director Fundador del IETS)minorStrategic or Co-development PartnerFormer founding director and current international consultant contributing expertise in health technology access and policy.
• Gobierno Nacional de ColombiaflagshipStrategic or Co-development PartnerAs an entity affiliated to the Ministry of Health since 2023, IETS works with national government to provide evidence for health policy decisions and system sustainability.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen): Germany's independent HTA institute producing benefit assessments and economic evaluations. Comparable to IETS for its scientific independence, methodological rigor, and policy-facing remit within a regulated health system.
• NICE (National Institute for Health and Care Excellence): The United Kingdom's national HTA body. Directly comparable to IETS in mandate, methodology (clinical and economic evaluation), and role informing reimbursement and clinical guidelines within a single-payer-adjacent health system.
• CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS): Brazil's national HTA commission under the Ministry of Health for the SUS public system. Highly comparable to IETS as a Latin American, government-affiliated HTA body producing binding recommendations on technology incorporation.
• CADTH (Canadian Agency for Drugs and Technologies in Health): Canada's federal HTA agency producing drug and non-drug technology evaluations, economic analyses, and recommendations to public payers — a near-direct methodological and institutional analogue to IETS at a national scale.
• CETSAI-ISALUD: Argentina's HTA center affiliated with ISALUD University; explicitly cited as a knowledge-exchange partner of IETS. Directly comparable as a Spanish-speaking HTA producer focused on policy-relevant evidence for Latin American decision-makers.
• IECS (Instituto de Efectividad Clínica y Sanitaria): Argentina's health technology assessment and health economics research institute. Comparable to IETS as a Spanish-speaking, Latin American HTA producer focused on economic evaluations, clinical guidelines, and policy-relevant research.
• INESSS (Institut national d'excellence en santé et en services sociaux): Quebec's HTA agency evaluating technologies, clinical guidelines, and care pathways — structurally analogous to IETS in producing evidence-based recommendations tied to provincial reimbursement decisions.
• AETS (Agencia de Evaluación de Tecnologías Sanitarias del ISCIII): Spain's national HTA unit within the Instituto de Salud Carlos III. Directly comparable to IETS in producing evidence-based evaluations, clinical practice guidelines, and reports for the Spanish national health system.

Broad incumbents

• AHRQ (Agency for Healthcare Research and Quality): US federal agency producing evidence syntheses, comparative effectiveness research, and clinical decision support. A broader-incumbent peer: overlaps with IETS on evidence generation and dissemination but operates at much larger scale across a federalized system.

Others

• RedETSA (Red de Evaluación de Tecnologías Sanitarias de las Américas): PAHO-coordinated network of HTA agencies in the Americas of which IETS is a member. Comparable as an ecosystem/network peer enabling knowledge exchange, methodology alignment, and cross-country collaboration that complement IETS's mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ietscolombia
• YouTubeyoutube.com/channel/UCuU90-Be9ZJNDT8G0HAg0_w
• Facebookfacebook.com/profile.php?id=61583005320244
• LinkedInlinkedin.com/company/ietscolombia
• Instagraminstagram.com/iets_colombia/?hl=es

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Evaluación Tecnológica en Salud